BAMG
WST icon

Brand Asset Management Group’s West Pharmaceutical WST Stock Holding History

Brand Asset Management Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-50
Closed -$14K – 270
2021
Q1 		$14K Hold
50
– – 0.01% 217
2020
Q4 		$14K Hold
50
– – 0.01% 191
2020
Q3 		$14K Hold
50
– – 0.01% 190
2020
Q2 		$11K Hold
50
– – 0.01% 198
2020
Q1 		$8K Hold
50
– – 0.01% 206
2019
Q4 		$8K Hold
50
– – 0.01% 258
2019
Q3 		$7K Hold
50
– – ﹤0.01% 264
2019
Q2 		$6K Hold
50
– – ﹤0.01% 289
2019
Q1 		$6K Buy
+50
New +$5.2K ﹤0.01% 270

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Brand Asset Management Group's WST Position: Q2 2021 in Review

Brand Asset Management Group sold out of West Pharmaceutical (WST) in Q2 2021, closing a stake of 50 shares — an estimated $14K sold.

Brand Asset Management Group first reported a position in WST in Q1 2019 and held it in 9 quarters. The position peaked at $14K in Q1 2021. 640 funds tracked by Wall St. Rank hold WST as of Q2 2021.

  • Brand Asset Management Group reported no remaining West Pharmaceutical position as of Q2 2021 after selling out during the quarter.
  • Brand Asset Management Group sold 50 West Pharmaceutical shares in Q2 2021, an estimated $14K.
  • Brand Asset Management Group first reported a position in West Pharmaceutical in Q1 2019 and held it in 9 quarters.
  • Brand Asset Management Group's West Pharmaceutical position peaked at $14K in Q1 2021.
  • 640 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2021.

Based on Brand Asset Management Group's 13F filing for Q2 2021, filed 9 Aug 2021.